Presentation is loading. Please wait.

Presentation is loading. Please wait.

TEXT, FOLLOW –UP AND THE CANCER REGISTRAR

Similar presentations


Presentation on theme: "TEXT, FOLLOW –UP AND THE CANCER REGISTRAR"— Presentation transcript:

1 TEXT, FOLLOW –UP AND THE CANCER REGISTRAR
NOW SHOWING TEXT, FOLLOW –UP AND THE CANCER REGISTRAR

2 STARRING PERFECT TEXT & FABULOUS FOLLOW-UP

3 CO-STARRING YOU!!!! Text documentation supporting your coding is critical. Text is where you really put your stamp on the abstract!!! It’s amazing to me, but some folks here at KCR can look at nothing more than the text of a case and tell you what facility it’s from and which registrar there abstracted it. They just have their own style. There are guidelines, but really very little right vs wrong way of doing text. Abstractor’s will have different styles as will different facilities…. Some facilities have very defined formats for entering text that each registrar is expected to use that format, while other facilities leave more up to each individual registrar.

4 Everybody’s Got A Story………..
Text tells “the story” in readable language that supports the coding Accurate, concise summary of the patient’s cancer Text serves to summarize the patient’s medical experience and the numerical codes then collapse the information into assigned data fields. If you only get one thing from this presentation, let it be that the purpose of text is to support your coding!

5 Text Uses…… Support coding Support unusual site/histology combos
Explain unusual abstract entries Document ambiguous terminology Document additional info or questions Yet again…..it’s the primary use Marynell talked to you about those suggested sites in the purple book….the ones where a topography code (CXX.X) is found next to a morphology code. Sometimes that’s just not going to work for you and you need to document why. Eventually, things are going to get weird and you’re going to run across THAT case Seen “the list” of amb terms by now…..it’s always good to have that verbage documented….you want that definitive diagnostic statement in your abstract Can be anything……it’s not unusual for us to see in an abstract “….discussed this case with X and she agreed that the code should be YYYY.”

6 And Even More Text Uses Support accuracy and validity of data
Eliminate the need to pull charts again Edit check verification Re-coding/re-staging of historical data Researcher/facility use What it’s ultimately all about!! GIGO—Garbage In Garbage Out Pulling charts=Not fun Much easier with good text See above—you don’t have to go looking for info again Facilities and researchers use (and don’t use) text in different ways

7 Text Uses At Central Registry
Validate codes in the abstract Sequence Extent Treatment Reconcile codes and consolidate abstracts from different facilities QC audits Seq: Is this the first cancer? If not, don’t describe the first in great detail….”Previously dx’d with ALL in 2005…….” Ext: Where is it? How far has the cancer spread? You’ve seen the layers of the colon wall…..does the tumor extend to the submucosa? All the way to the peritoneum? Tx: Like clinical trials, capturing first course treatment information is becoming more and more important, so it’s key to document that info in the treatment notes or in text Patients are seen at multiple facilities….certainly not unusual for a patient to be diagnosed in say, Pikeville, but then be referred to UK for all of their treatment. Both facilities will abstract that case and the info will be combined here at the central registry. Good text helps that process go smoothly and also helps if things aren’t matching up. QC audits are our way of ensuring that we have quality data.

8 Critical Data Items Age ** DOB Sex Race Sequence number Stage
Date of diagnosis Laterality Primary site Histology Behavior Grade Dates and types of all treatments Include age at diagnosis, but DOB is also nice…these abstracts are going to be read for years so it’s nice to have that reference in there Age changes, but DOB doesn’t

9 Picturing this??? Promise it won’t be that bad….

10 It’s not the amount of text… it’s how you use it!
Be concise- quality is more important than quantity Only document what’s relevant to the site/disease Use abbreviations Lots of useless info doesn’t help anyone. Keep your text simple! KISS! Don’t repeat…you only have to document once! Otherwise, don’t record PSA test values/results for a man dx’d with lung cancer….stick to the tests for the specific cancer being dx’d or tx’d Abbreviations are totally acceptable!!! Don’t be afraid to abbreviate when entering your text.

11 Abbreviations!!! Use ‘em…..
Use accepted abbreviations from the Abstractor’s Manual available at Appendix I (Common Acceptable Abbreviations) We gave you a whoooooooole big list of them in the Abstractor’s Manual!

12 ….But Use Caution! Make sure your abbreviations aren’t confusing
Spell out, at least once, any abbreviation that might not be easily recognized Use abbreviations in context SCC---is that small cell carcinoma or squamous cell carcinoma??? Stick to the list!!! For survey---they will read text and they need to be able to understand it! DLBCL---diffuse large b-cell lymphoma Place abbreviation in a place where the context make sense. Example “ MD “ alone on a line is confusing. Is it “doctor” or is it “moderately differentiated”??

13 In addition to abbreviations, using symbols is also acceptable.
YES. <, >, =, & + (positive), x (times) 2/7 (two of seven) Also POS (+)

14 You can omit vowels or use apostrophes to shorten words.
YES. Glsn (Gleason), Blm-Rch (Bloom-Richardson) Rec’d, dx’d LNs

15 Match the abbreviations!
Abdomen ANT Bilateral BX Biopsy ABD Bone Marrow BIL Anterior BM

16 Health and Physical: Demographics
Name(s) Social Security Number Age….and DOB added is nice Sex Race Ethnicity Birth place It’s good practice to include these in your text because they are great for quick visual edits….you can double check age vs DOB, Hisp origin field, sex vs. first name

17 History and Physical Any previous cancer dx? When? Where?
Describe the symptoms leading to the current admission (inpt or outpt) for dx and/or tx Remember to focus text on the cancer being dx’d and/or tx’d at this time BE SURE TO INCLUDE THE REASON FOR THE CURRENT VISIT!!!!!!

18 History and Physical Was this cancer dx’d at your facility or a different one? Where? (give the facility, office, etc.) Give the date, site and histology Has this cancer been previously treated? Procedures, treatment, drugs, dose Dates Location End with your initials and the date Reference point for when data was obtained

19 Example W/F, non-Hispanic with pelvic pain growing worse over the past 3 months. US at outside facility showed solid 10 cm mass rt ovary. Referred here for eval and tx. TR 6/15/16

20 Imaging Include the date, scan type, and facility where performed
Include only info relevant to the primary site Any positive findings Any negative findings that define stage Support your codes for CS Tumor Size, CS Extension, CS Lymph Nodes, CS Mets at Dx End with your initials and the date Aka…x-rays, scans, and ultrasounds For neg--- CT neg for mets

21 End with your initials and the date
Scopes Include the date, scope type, facility where performed, and the relevant findings End with your initials and the date Proximal/distal from what reference point

22 Lab Work Document tumor markers and site specific factors
Document factors affecting prognosis or staging Gleason score (prostate) PSA (prostate) ER/PR status (breast) CA-125 (ovary) CEA (colorectal) Her2 expression Copying over your list of site specific factors into your text is fine, but use that opportunity to justify your codes.

23 Lab Work 10/21/16 UK: CEA 12.3 (nl < 5.0 ng/ml) TR 11/13/16
Include : Date of Test Facility Where Performed Result (value) Normal Range Your Initials with Date 10/21/16 UK: CEA 12.3 (nl < 5.0 ng/ml) TR 11/13/16

24 Operative Findings Include the date, name of procedure, facility where performed, relevant findings and may also include Organs removed Any differences between intended procedure and actual procedure Important site, size or staging info End with your initials and the date Tumor size, extension, seeding, LN involvement Sometimes procedures don’t go as planned….. e.g. find unresectable tumor in OR

25 Pathology Include the date, tissue taken, report number, facility where performed, site tissue was taken from, final diagnosis Include results regarding size, location, histology, grade, extension, LNs Comments and addenda are important and should also be included End with your initials and the date Bx, resection, cytology Include microscopic information if relevant to histology Metastatic involvement

26 Site Document the primary site (topography) as described in the medical record Document laterality End with your initials and the date Be sure to follow schema directed instructions for choosing reported topography (site) Be brief!

27 Histology Document the date and source of tissue
Support your code for the primary tumor type Include the final dx from cyto, path or clinical assessment Document behavior and grade End with your initials and the date Support your code, but be brief.

28 Staging Document TNM staging and who staged the patient
Document whether there is clinical and/or pathologic staging For Collaborative Stage, show the original measurements and include the sources Include any info for Site Specific Factors if not covered elsewhere End with your initials and the date Support your code Include statements about tumor extent, lymph nodes, metastases, type of evaluation, and site specific factors

29 Other Include info for :
Date of Dx, if not covered in earlier text Class of case Therapy planned and/or received including type, volume, modality Following physicians Follow-up info sources Follow-up info will typically be added here each year…along with your initials and the date Support your code

30 Reabstracting Audits! Are often performed using text information only….data not documented will be counted as errors.

31 Conflicting Info What if you follow the rules and your staging doesn’t match the physician staging? Code according to the rules and document how you arrived at your code (i.e. support your coding with text)

32 Follow-Up Systematic process of obtaining accurate information, at least annually, on the patient’s health, vital status, and progression of disease

33 Follow-Up Can assist in the early identification of recurrence
Assists physician’s in getting former cancer patients to return for treatment or checkups Encourages periodic examination of cancer patients since they are prone to develop other cancers One very, very important word…..survival

34 Follow-Up Rules Follow-up info necessary for analytic cases only, with the following exceptions Patients who are currently residing in foreign countries e Patients whose only malignancy is carcinoma in situ of the cervix Analytic cases: Case diagnosed and/or receiving all or part of the first course of therapy at your facility----Class of case 00-22 The exceptions are not required to be followed regardless of the class of case

35 The College (aka ACoS) Follow-up is considered delinquent by ACoS if info is not obtained and documented within 15 months of the patient’s previous date of last contact For an approved program, a follow-up rate of 90% of a hospital’s analytic cases in the past 5 years is needed to be in compliance American College of Surgeons

36 Follow-Up with KCR Current follow-up must be reported to KCR for every case dx’d since 1995 that is class 00-22 Considered current if Date of Last Contact is within 15 months of current date CPDMS.net can create a report for patients needing updated follow-up

37 Word To The Wise….. Always maintain the highest follow-up rate possible! Falling behind is trouble that’s easy to get into….and hard to get out of Easier and less worry for you…..It’s a NIGHTMARE to catch up once you get behind!!!!!!! Survival rates and stats

38 What To Collect Date of Last Contact Survival status Current address
Disease status Recurrence info Additional treatment received Cause of death, if deceased Method of obtaining follow-up Date of Last Contact: May be date of death or most current date the patient is known to be alive Survival Status: Alive ( w/ or w/o disease) or dead (related or unrelated to ca?) Current address: May be different than original Disease status: Ever disease free and if so what is the date Recurrence info: Date, type and site Additional treatment: ****Types and dates of therapy given after the DLC Cause of death: Include any autopsy info if available Method of follow-up: Includes any change in name or address of the primary/alternate contact persons or in the method for purusing follow-up on the next attempt

39 A Few Words About Treatment
Obtaining complete first course treatment info is extremely important Follow your registry rules, but a brief documentation (date, type, drug(s), start & stop dates) in the treatment notes section is ideal Must be doc somewhere…either in text or in tx notes…not both Be brief!! Putting info in tx notes will allow it to come out on the tx report (web) it will save you phone calls because other registrar’s will have access

40 Questions? Resources for clarification: Your facility manager for facility specific preferences and your regional coordinator.


Download ppt "TEXT, FOLLOW –UP AND THE CANCER REGISTRAR"

Similar presentations


Ads by Google